Clinical and Imaging Markers of Prodromal Parkinson's Disease
The diagnosis of Parkinson's disease (PD) relies on the clinical effects of dopamine deficiency, including bradykinesia, rigidity and tremor, usually manifesting asymmetrically. Misdiagnosis is common, due to overlap of symptoms with other neurodegenerative disorders such as multiple system atr...
Main Authors: | Eldbjørg Hustad, Jan O. Aasly |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-05-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fneur.2020.00395/full |
Similar Items
-
Sleep Spindles and Fragmented Sleep as Prodromal Markers in a Preclinical Model of LRRK2-G2019S Parkinson's Disease
by: Lindsey M. Crown, et al.
Published: (2020-05-01) -
Increased Mortality in Young-Onset Parkinson’s Disease
by: Eldbjørg Hustad, et al.
Published: (2021-09-01) -
Prodromal Markers of Parkinson's Disease in Patients With Essential Tremor
by: Xi-Xi Wang, et al.
Published: (2020-08-01) -
Future Perspectives on the Relevance of Auditory Markers in Prodromal Parkinson's Disease
by: Evelien De Groote, et al.
Published: (2020-07-01) -
CSF total and oligomeric α-Synuclein along with TNF-α as risk biomarkers for Parkinson’s disease: a study in LRRK2 mutation carriers
by: Nour K. Majbour, et al.
Published: (2020-05-01)